Page 52 of pharmaceuticals

Balaxi Pharmaceuticals, Q2FY23, quarter results, net profit, health news, pharma news,

Balaxi Pharmaceuticals consolidated net profit rises over 28 percent in Q2FY23

Moreover, sales rose 23 percent to Rs 86.38 crore in the quarter ended September 2022 as against Rs 70.23 crore…

November 7, 2022 12:26 IST

Lupin, Lupin Limited, Asthma, fixed-dose triple drug combination, health news, pharma news,

USFDA tentatively approves Lupin’s birth control tablets

Drospirenone Tablets (RLD Slynd) had estimated annual sales of USD 141 million in the United States, as per IQVIA MAT…

November 7, 2022 12:08 IST

Pfizer, Pfizer drug portfolio, healthcare news, pharma news,

IOL Chemicals and Pharmaceuticals to supply heartburn drug API in European market

The company started production of Pantoprazole Sodium Sesquihydrate in Q3 FY 2020 at its Punjab-based facility.

November 7, 2022 11:34 IST

Dr Reddy's, Dr. Reddy's laboratories, quarter results, health news, pharma news,

Dr. Reddy’s profit jumps 12% YoY to Rs. 1,114 crore; Revenue rises over 9%

North America contributed the most to the overall sales of Dr Reddy’s in the quarter, followed by emerging markets and…

October 28, 2022 21:16 IST

Sanofi, Dupixent, flu vaccines, health news, pharma news, healthcare news,

Sanofi witnesses faster profit growth on Dupixent, flu vaccine

Reportedly, revenue from exzema and asthma drug Dupixent, jointly developed with Regeneron, jumped by a currency-adjusted 44.5% to 2.3 billion…

October 28, 2022 14:06 IST

GSK, otilimab, investigational monoclonal antibody, Rheumatoid Arthritis (RA), Health news, pharma news,

GSK to skip regulatory submissions for its investigational drug

Rheumatoid Arthritis (RA) is a chronic, systemic inflammatory condition characterised by pain, joint swelling, stiffness, joint destruction and disability.

October 27, 2022 15:02 IST

Roche, Vabysmo, Phase III trial, retinal vein occlusion, edema, blindness, health news, pharma news,

Roche’s drug improves sight of people with vision-threatening eye disorder

In both studies, Vabysmo was generally well tolerated and the safety profile was consistent with previous trials, the company claims.

October 27, 2022 12:39 IST

Alembic Pharmaceuticals, cancer injection, Paclitaxel Injection, breast cancer, USFDA, Health news, pharma news,

USFDA gives approval to Alembic Pharmaceuticals’ cancer injection

According to IQVIA, Paclitaxel Injection USP has an estimated market size of US$ 26 million for twelve months ending June…

October 27, 2022 11:09 IST

Bristol Myers Squibb, Revlimid, third-quarter revenue, third quarter results, health news, pharma news,

Bristol Myers’ Q3 sales dip due to generic competition of its cancer drug

Moreover, Bristol Myers reported third-quarter revenue of $11.22 billion, down from $11.62 billion a year ago.

October 26, 2022 16:22 IST

AstraZeneca’s experimental drug shows positive outcomes in advanced breast cancer study

The company claims that the safety profile of capivasertib plus Faslodex was similar to that observed in previous trials evaluating…

October 26, 2022 15:28 IST

Spectrum Pharmaceuticals, USFDA, lung cancer drug, poziotinib, Luye Pharma, health news, pharma news,

USFDA approves Johnson & Johnson’s blood cancer therapy, Tecvayli

TECVAYLI is Janssen’s fourth approved treatment for multiple myeloma and this further diversifies the company’s industry-leading oncology portfolio and deepens…

October 26, 2022 12:16 IST

Astrazeneca, AstraZeneca India, Dapagliflozin, CDSCO, health news, pharma news,

AstraZeneca’s asthma drug fails in trial study for chronic immune disease

Earlier this year, Sanofi and partner Regeneron’s Dupixent became the first treatment to target underlying causes of the disease after…

October 25, 2022 18:05 IST

Immunotherapy drug shows promising results in patients with advanced skin cancer

Although the trial was small, its results were similar to those reported with pembrolizumab and cemiplimab.

October 25, 2022 12:56 IST

Novartis, Brain cancer, pediatric cancer, healthcare news, pharma news,

Novartis’ earning declines 4 percent to $4.28 billion; Outlook of Sandoz improves

Novartis also announced that Richard Saynor, will be appointed CEO designate of Sandoz and step down from the Executive Committee…

October 25, 2022 12:19 IST

Pharmaceuticals, paracetamol, indian pharmaceutical sector, health news, pharma news,

Novartis’ investigational oral monotherapy shows positive results against rare blood disease

The pharma major also claimed that Iptacopan was well tolerated with a favorable safety profile consistent with previously reported data.

October 24, 2022 11:56 IST

How biocatalysis is improving active pharmaceutical ingredient production?

Biocatalytic processing has several advantages over conventional approaches. Biocatalysis is both environmentally friendly and cost-effective.

October 22, 2022 12:00 IST

Lupin, Sunovion, inhalation brands, health news, pharma news,

Lupin inks agreement to acquire two inhalation brands from Sunovion

The pharma also announced that it expects the transaction to be accretive to earnings in the first year.

October 21, 2022 15:55 IST

Lupin launches new drug for schizophrenia treatment in United States

Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 112 million in the U.S. (IQVIA MAT August 2022).

October 21, 2022 15:37 IST

Related News

Aadhaar Card update October 2025: Here’s how to change name, address, date of birth and phone number online in simple steps

Who is Alexandr Wang? The 28-year-old hired by Mark Zuckerberg for $14 billion to head Meta’s Superintelligence Labs

H-1B Fears Ease as USC Sees Record Indian Enrolments, Dean Says

Indian students enrollment at record high says USC dean, explains H-1B benefits despite fees

Live Nobel Peace Prize 2025, Live Nobel Prize 2025, Nobel Prize for Peace, Trump Nobel Peace Prize, Nobel Peace Prize Announcement, Nobel Peace Prize 2025 Time, Nobel Prize, Nobel Prize 2025, Nobel Peace Prize 2025, Nobel Peace Prize Announcement, Donald Trump Nobel Peace Prize, Nobel Peace Prize Winner, Who Won Nobel Peace Prize, Nobel Peace Prize Nominee, Nobel Prize News 2025, Nobel Peace Prize, nobel peace prize 2025,nobel prize 2025,nobel prize for peace,trump nobel peace prize,nobel peace prize announcement, nobel peace prize 2025 time

Nobel Peace Prize 2025 Live Updates: Maria Corina Machado’s name was leaked? Nobel institute says ‘highly likely it’s espionage’

Employee quits google job, Google Manager Quits Rs 3.4 Crore Job

Google manager quits Rs 3.4 crore job, says ‘the work was pleasant, but…’

Who was Konstantin Galish? Ukrainian crypto blogger found dead amid market crash

World News22 min ago

32-year-old Ukrainian crypto investor and blogger Kostya Kudo, co-founder and CEO of a trading academy, was found dead in his Lamborghini in Kyiv during a major cryptocurrency crash. Reports suggest he died by suicide. The crash has been linked to US President Trump’s tariff announcement on Chinese imports.

View all shorts